Skip to Main Content
Priorities
Approach
About
Newsroom
Menu
Newsroom
Billionaires Ken Griffin and David Geffen Give $400 Million to Fight Cancer
December 12, 2023
READ MORE
Type:
Research
All
In the News
Announcements
Research
In Brief
Topics:
Science & Medicine
All
Communities
Education
Enterprise & Innovation
Freedom & Democracy
Science & Medicine
Upward Mobility
Ken Griffin
Sort By:
Newest
Newest
Oldest
Science & Medicine
Assessment of Heterogeneity Among Participants in the Parkinson's Progression Markers Initiative Cohort Using Α-Synuclein Seed Amplification: A Cross-Sectional Study
Research
May 1, 2023
Lancet
Science & Medicine
Solving Medicine’s Data Bottleneck: Nightingale Open Science
Research
May 9, 2022
Nature Medicine
Science & Medicine
An Algorithmic Approach to Reducing Unexplained Pain Disparities in Underserved Populations
Research
January 21, 2021
Nature Medicine
No results found.
Please select a different news type or topic.
Close
Priorities
Education
Science & Medicine
Communities
Upward Mobility
Freedom & Democracy
Enterprise & Innovation
Learn More
Approach
Griffin Catalyst reflects Ken Griffin’s strategic approach to tackling the world’s greatest challenges, advancing innovative, data-driven, and timely solutions.
Learn More
About
Griffin Catalyst is the civic engagement initiative of Ken Griffin, encompassing his philanthropic and community impact efforts.
Learn More
Newsroom
In the News
Announcements
Research
In Brief
Learn More
Close